Complete Filing Data
MOLECULAR PARTNERS AG reported Cash And Cash Equivalents of $82.65 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean MOLECULAR PARTNERS AG did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Selling General And Administrative Expense | $15.2M | $17.6M | $19.4M | $22.2M | $17.5M | $11.6M | $13.5M |
| Revenue From Contracts With Customers | $0.00 | $5.0M | $7.0M | $189.6M | $9.3M | $9.3M | $20.4M |
| Research And Development Expense | $40.2M | $48.6M | $48.8M | $50.7M | $55.7M | $56.1M | $43.5M |
| Profit Loss From Operating Activities | -$58.1M | -$61.2M | -$61.1M | $116.6M | -$63.4M | -$58.3M | -$36.7M |
| Profit Loss Before Tax | -$61.6M | -$54.0M | -$62.0M | $117.9M | -$63.8M | -$62.8M | -$36.3M |
| Profit Loss | -$61.7M | -$54.0M | -$62.0M | $117.9M | -$63.8M | -$62.8M | -$36.3M |
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | -$3.8M | -$485.0K | -$2.0M | $5.3M | $8.0M | -$1.5M | -$4.7M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $5.0K | -$10.0K | -$16.0K | -$17.0K | -$3.0K | -$26.0K | -$14.0K |
| Other Comprehensive Income | -$3.8M | -$495.0K | -$2.0M | $5.3M | $8.0M | -$1.5M | -$4.7M |
| Income Tax Expense Continuing Operations | $2.0K | $2.0K | $0.00 | $0.00 | $2.0K | -$11.0K | $17.0K |
| Comprehensive Income | -$65.5M | -$54.5M | -$64.0M | $123.2M | -$55.8M | -$64.3M | -$41.0M |
| Adjustments For Income Tax Expense | $2.0K | $2.0K | $0.00 | $0.00 | $2.0K | -$11.0K | $17.0K |
| Income Taxes Paid Refund Classified As Operating Activities | $0.00 | $0.00 | $0.00 | $0.00 | $2.0K | $0.00 | |
| Expense Of Restructuring Activities | $2.7M | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $82.7M | $63.9M | $67.3M | $87.9M | $71.8M | $133.7M | $75.7M | $99.0M |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $714.0K | $705.0K | $575.0K | $1.2M | $933.0K | $1.5M | $1.0M | |
| Purchase Of Investments In Short Term Time Deposits Classified As Investing Activities | $66.3M | $240.0M | $277.8M | $299.4M | $88.9M | $73.4M | $76.0M | |
| Purchase Of Intangible Assets Classified As Investing Activities | $0.00 | $18.0K | $233.0K | $240.0K | $374.0K | $232.0K | $833.0K | |
| Other Inflows Outflows Of Cash Classified As Operating Activities | -$15.0K | -$12.0K | -$15.0K | -$14.0K | -$8.0K | -$9.0K | -$9.0K | |
| Cash Flows From Used In Operating Activities | -$51.3M | -$59.2M | -$59.0M | $118.6M | -$91.0M | -$29.0M | -$1.2M | |
| Cash Flows From Used In Investing Activities | $72.5M | $40.5M | $44.6M | -$101.1M | -$22.2M | -$21.7M | -$19.8M | |
| Cash Flows From Used In Financing Activities | -$1.1M | $14.4M | -$1.2M | -$1.6M | $50.6M | $113.2M | -$227.0K | |
| Adjustments For Increase Decrease In Trade And Other Payables | $65.0K | $524.0K | -$812.0K | -$5.3M | $1.7M | $3.4M | -$270.0K | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -$546.0K | -$670.0K | $535.0K | $1.1M | $1.1M | $1.3M | $473.0K | |
| Adjustments For Increase Decrease In Contract Liabilities | $0.00 | -$4.3M | -$5.7M | -$25.2M | -$10.7M | $17.6M | -$20.4M | |
| Adjustments For Increase Decrease In Accrued Expenses | $343.0K | $161.0K | $45.0K | -$2.4M | $2.3M | $1.0M | $217.0K | |
| Adjustments For Decrease Increase In Trade And Other Receivables | $485.0K | -$347.0K | -$933.0K | $25.3M | -$23.4M | -$552.0K | $49.6M | |
| Trade And Other Current Receivables | $1.8M | $2.3M | $2.0M | $1.0M | $25.7M | $2.8M | ||
| Trade And Other Current Payables | $1.8M | $1.9M | $1.3M | $2.1M | $7.4M | $5.8M | ||
| Shortterm Deposits Not Classified As Cash Equivalents | $10.4M | $85.6M | $119.6M | $161.2M | $61.0M | $40.0M | ||
| Retained Earnings | -$311.8M | -$246.3M | -$191.8M | -$127.8M | -$251.0M | -$195.2M | ||
| Noncurrent Liabilities | $10.7M | $6.1M | $7.5M | $9.8M | $18.5M | $22.7M | ||
| Noncurrent Lease Liabilities | $2.4M | $1.2M | $2.4M | $3.7M | $4.9M | $6.0M | ||
| Noncurrent Assets | $5.2M | $4.2M | $5.9M | $7.5M | $8.5M | $9.7M | ||
| Liabilities | $21.8M | $16.9M | $21.9M | $27.1M | $65.4M | $80.3M | ||
| Intangible Assets Other Than Goodwill | $2.0K | $49.0K | $212.0K | $271.0K | $331.0K | $347.0K | ||
| Equity And Liabilities | $102.1M | $158.5M | $198.4M | $262.3M | $172.7M | $187.5M | ||
| Current Liabilities | $11.0M | $10.8M | $14.4M | $17.3M | $46.9M | $57.7M | ||
| Current Lease Liabilities | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | ||
| Current Assets | $96.9M | $154.3M | $192.5M | $254.8M | $164.2M | $177.8M | ||
| Current Accrued Expenses And Other Current Liabilities | $8.1M | $7.7M | $7.5M | $7.5M | $10.0M | $7.7M | ||
| Assets | $102.1M | $158.5M | $198.4M | $262.3M | $172.7M | $187.5M | ||
| Other Current Assets | $2.0M | $2.5M | $3.6M | $4.6M | $5.7M | |||
| Current Contract Liabilities | $0.00 | $4.3M | $6.4M | $28.3M | $42.9M | |||
| Issue Of Equity | $15.6M | $350.0K | $51.5M | $113.6M | ||||
| Adjustments For Decrease Increase In Other Current Assets | $335.0K | $237.0K | $1.4M | $1.8M | -$4.4M | $1.0M | ||
| Adjustments For Decrease Increase In Prepaid Expenses And Accrued Income | -$4.4M | $1.0M | $453.0K | |||||
| Property Plant And Equipment Including Rightofuse Assets | $5.2M | $4.2M | $5.7M | $7.2M | ||||
| Noncurrent Contract Liabilities | $0.00 | $3.6M | $6.9M | $2.9M | ||||
| Property Plant And Equipment | $7.2M | $8.1M | $9.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Proceeds From Investments In Short Term Time Deposits Classified As Investing Activities | $137.8M | $277.0M | $319.4M | $199.2M | $67.9M | $52.8M | $56.6M |
| Payments Of Lease Liabilities Classified As Financing Activities | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | $1.3M | $1.2M |
| Increase Decrease In Cash And Cash Equivalents | $18.8M | -$3.4M | -$20.6M | $16.1M | -$61.9M | $58.0M | -$23.2M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$1.4M | $894.0K | -$5.1M | $258.0K | $701.0K | -$4.5M | -$2.0M |
| Proceeds From Exercise Of Options | $40.0K | $31.0K | $250.0K | $267.0K | $840.0K | $1.0M | |
| Proceeds From Issuing Shares | 0.00 | 17.3M | 0.00 | 0.00 | 51.5M | 113.6M | 0.00 |
| Payments To Acquire Or Redeem Entitys Shares | 0.00 | 0.00 | 631.0K | 0.00 | 0.00 | ||
| Payments For Share Issue Costs | $0.00 | $1.7M | $0.00 | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $-1.65 | $-1.59 | $-1.89 | $3.54 | $-2.06 | $-2.51 | $-1.69 |
| Basic Earnings Loss Per Share | $-1.65 | $-1.59 | $-1.89 | $3.63 | $-2.06 | $-2.51 | $-1.69 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating Expense | $58.1M | $66.2M | $68.1M | $73.0M | $73.2M | $67.7M | $57.0M |
| Finance Income Cost | -$3.5M | $7.2M | -$876.0K | $1.2M | -$365.0K | -$4.4M | $389.0K |
| Finance Income | $1.5M | $7.2M | $4.3M | $1.9M | $191.0K | $367.0K | $1.6M |
| Finance Costs | $5.0M | $38.0K | $5.2M | $619.0K | $556.0K | $4.8M | $1.2M |
| Adjustments For Sharebased Payments | $4.4M | $4.1M | $5.2M | $5.1M | $4.1M | $2.9M | $2.4M |
| Interest Received Classified As Investing Activities | $1.7M | $4.2M | $3.8M | $494.0K | $70.0K | $569.0K | $1.4M |
| Interest Paid Classified As Operating Activities | $18.0K | $26.0K | $34.0K | $646.0K | $583.0K | $219.0K | $91.0K |
| Increase Decrease Through Sharebased Payment Transactions | $4.4M | $4.1M | $5.2M | $5.1M | $4.1M | $2.9M | $2.4M |
| Adjustments For Finance Income | $1.5M | $7.2M | $4.3M | $1.9M | $191.0K | $367.0K | $1.6M |
| Adjustments For Finance Costs | $5.0M | $38.0K | $5.2M | $619.0K | $556.0K | $4.8M | $1.2M |
| Adjustments For Depreciation And Amortisation Expense | $2.1M | $2.4M | $2.4M | $2.4M | $2.6M | $2.9M | $2.5M |
| Adjustment For Exchange Gains Losses On Working Capital Positions | $18.0K | $39.0K | $21.0K | $98.0K | $144.0K | -$6.0K | -$604.0K |
| Increase Decrease Through Exercise Of Options | $1.0K | $40.0K | $31.0K | $250.0K | $267.0K | $840.0K | $1.0M |
| Other Income | $0.00 | $0.00 | $44.0K | $424.0K | $0.00 | $0.00 | |
| Noncurrent Provisions For Employee Benefits | $8.1M | $4.9M | $5.1M | $2.6M | $6.7M | $13.7M | |
| Issued Capital | $4.0M | $4.0M | $3.6M | $3.6M | $3.2M | $2.9M | |
| Additional Paidin Capital | $389.2M | $384.9M | $365.5M | $360.3M | $355.0M | $299.5M | |
| Treasury Shares | 1.1M | 981.0K | 981.0K | 981.0K | 0.00 |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 9, 2026.